A 52-Week Placebo-Controlled Study Evaluating the Safety of Varenicline
Status:
Completed
Trial end date:
2005-03-01
Target enrollment:
Participant gender:
Summary
The primary purpose of this study is to obtain safety information on cigarette smokers
treated with 52 weeks of varenicline regardless of smoking status.